908 Devices Inc. (MASS) stock
MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/3038% above fair value
$9.19−0.55 (-5.65%)
Close on Nov 16, 2026Market cap $379.86MP/E –Yield –
908 Devices ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
908 Devices's ebitda for the twelve months ending Jun 30, 2026 was -$34.22M. For fiscal 2025 it was -$34.96M. The highest annual figure on record is -$4.98M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$34.96M | – |
| FY2024 | Dec 31, 2024 | -$52.71M | – |
| FY2023 | Dec 31, 2023 | -$40.37M | – |
| FY2022 | Dec 31, 2022 | -$33.77M | – |
| FY2021 | Dec 31, 2021 | -$21.14M | – |
| FY2020 | Dec 31, 2020 | -$4.98M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.45M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.75M | – |
| Q4 FY2025 | Dec 31, 2025 | $4.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.74M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.31M | – |
| Q3 FY2024 | Sep 30, 2024 | -$23.08M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.04M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.28M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.31M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.35M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.76M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.70M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.06M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.25M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.24M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.22M | -409.5% |
| Q1 FY2021 | Mar 31, 2021 | -$5.67M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.67M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.09M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.33M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.56M | – |
See a number that looks wrong?